Design, synthesis and computational evaluation of 1,2,3-triazole-Schiff base hybrid as AKT1 inhibitor for breast cancer

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Design, synthesis and computational evaluation of 1,2,3-triazole-Schiff base hybrid as AKT1 inhibitor for breast cancer'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Chemistry